Arcturus Therapeutics Holdings SG&A Expense (TTM) Insights

Arcturus Therapeutics Holdings Inc (ARCT)

22.03 +0.26 (+1.19%) USD | NASDAQ | Sep 27, 16:00

21.55 -0.48 (-2.18%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2024	53.05M
March 31, 2024	53.96M
December 31, 2023	52.87M
September 30, 2023	52.22M
June 30, 2023	51.34M
March 31, 2023	49.10M
December 31, 2022	46.07M
September 30, 2022	45.02M
June 30, 2022	43.39M
March 31, 2022	42.44M
December 31, 2021	41.45M
September 30, 2021	39.68M
June 30, 2021	34.39M
March 31, 2021	28.77M
December 31, 2020	23.22M
September 30, 2020	15.97M
June 30, 2020	14.28M
March 31, 2020	13.32M
December 31, 2019	12.66M
September 30, 2019	14.31M
June 30, 2019	14.24M
March 31, 2019	19.02M
December 31, 2018	20.58M

Date	Value
September 30, 2018	19.78M
June 30, 2018	18.81M
March 31, 2018	11.64M
December 31, 2017	7.718M
September 30, 2017	4.461M
June 30, 2017	2.826M
March 31, 2017	3.17M
December 31, 2016	3.448M
September 30, 2016	2.978M
June 30, 2016	2.943M
March 31, 2016	2.743M
December 31, 2015	2.574M
September 30, 2015	5.103M
June 30, 2015	5.193M
March 31, 2015	5.339M
December 31, 2014	5.839M
September 30, 2014	5.444M
June 30, 2014	5.247M
March 31, 2014	4.774M
December 31, 2013	3.224M
September 30, 2013	2.365M
June 30, 2013	1.441M
March 31, 2013	0.764M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

12.66M

Minimum

Dec 2019

53.96M

Maximum

Mar 2024

36.38M

Average

41.94M

Median

SG&A Expense (TTM) Benchmarks